HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem Has High Hopes For New ACT, Selsun Launches, Raises Guidance

This article was originally published in The Rose Sheet

Executive Summary

Chattem, unfazed by the state of the economy and supremely confident in new launches within its ACT, Gold Bond and Selsun brands, is setting its fiscal 2009 expectations at 60 cents to 75 cents per share above its 2008 guidance

You may also be interested in...



Chattem Considering Expansion Via Technology, Licensing Deals

Chattem is ready to pursue technology acquisitions or licensing deals within health and beauty and likely will make a move within the next few years, according to CEO Zan Guerry

Chattem Considering Expansion Via Technology, Licensing Deals

Chattem is ready to pursue technology acquisitions or licensing deals within health and beauty and likely will make a move within the next few years, according to CEO Zan Guerry

Kline Expects C&T Growth In 2011, But Consumers May Continue To Snub Lux

Kline & Company expects the cosmetics and toiletries market to pick up in two years; however, growth will be checked by tighter regulation and lasting consumer conservatism

Related Content

UsernamePublicRestriction

Register

RS015806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel